Generic HIV drugs will widen US treatment net.
Amy
A
Maxmen
D000225:Adenine / Q000031:analogs & derivatives / Q000191:economics; D019380:Anti-HIV Agents / Q000191:economics* / Q000600:supply & distribution* / Q000627:therapeutic use; D002017:Budgets; D002219:Carbamates / Q000191:economics; D003362:Cost-Benefit Analysis; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000191:economics; D004338:Drug Combinations; D016527:Drug Costs / Q000639:trends; D016568:Drugs, Generic / Q000191:economics* / Q000600:supply & distribution* / Q000627:therapeutic use; D000068257:Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D000069545:Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D035082:Federal Government; D006801:Humans; D063065:Organophosphonates / Q000191:economics; D010078:Oxazines / Q000191:economics; D010330:Patents as Topic; D015363:Quinolones / Q000191:economics; D013844:Thiazoles / Q000191:economics; D014481:United States
D019380:Anti-HIV Agents; D002219:Carbamates; D004338:Drug Combinations; D016568:Drugs, Generic; D000068257:Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D000069545:Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D063065:Organophosphonates; D010078:Oxazines; D015363:Quinolones; D013844:Thiazoles; D003841:Deoxycytidine; D000225:Adenine